Geurt Stokman

OBICETRAPIB AND EZETIMIBE REGRESS ATHEROSCLEROTIC LESIONS ON ATORVASTATIN BACKGROUND

Jose Inia, Nanda Keijzer, Nicole Worms, Anita Van Nieuwkoop-Van Straalen et autres

OBICETRAPIB ON TOP OF EZETIMIBE INCREASES NET FECAL STEROL LOSS BY LOWERING INTESTINAL CHOLESTEROL ABSORPTION AND ENHANCING TRANSINTESTINAL CHOLESTEROL EXCRETION

Leo Zhang, Nanda Keijzer, Nicole Worms, Anita Van Nieuwkoop-Van Straalen et autres

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background

José A. Inia, Leo H. Zhang, Nanda Keijzer, Nicole Worms et autres

nl, us (code pays fourni par la source)

Abstract 4368587: Obicetrapib in combination with ezetimibe on top of atorvastatin regresses atherosclerotic plaque lesions in APOE*3-Leiden.CETP mice

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

nl (code pays fourni par la source)

Resmetirom protects against diet-induced MASLD and reduces atherosclerosis development in obese Ldlr-/-.Leiden mice

Eveline Gart, Geurt Stokman, Anita M. van den Hoek, José A. Inia et autres

nl (code pays fourni par la source)

Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

nl (code pays fourni par la source)

Obicetrapib reduces atherosclerosis and vascular inflammation, mainly by reducing non-HDL cholesterol, improves lesion stability and adds to the beneficial effects of ezetimibe

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

nl (code pays fourni par la source)

† Obicetrapib reduces atherosclerosis and vascular inflammation, mainly by reducing non-HDL-C, improves lesion stability adding to the beneficial effect of ezetimibe

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

† Obicetrapib alone and in combination with ezetimibe increases reverse cholesterol transport and does not affect VLDL production

Elsbet Pieterman, Geurt Stokman, Nanda Keijzer, Nicole Worms et autres

Obicetrapib alone and in combination with ezetimibe reduces non-HDL-cholesterol by enhanced LDL-receptor-mediated VLDL clearance and increased net fecal sterol excretion in apoe*3-leiden.cetp mice

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

nl (code pays fourni par la source)

Obicetrapib alone and in combination with ezetimibe reduces atherosclerotic lesion size and severity in ApoE*3-Leiden.CETP mice

José A. Inia, Nanda Keijzer, Nicole Worms, Anita van Nieuwkoop et autres

nl (code pays fourni par la source)

THU-294 Resmetirom protects against diet-induced MASLD and reduces atherogenic risk factors in obese Ldlr-/-.Leiden mice

Eveline Gart, Geurt Stokman, Robert Kleemann, Martine C. Morrison